Medicover AB (LTS:0RPS) Other Long-Term Liabilities: kr622 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RPS Medicover AB LTS:0RPS
87 GF Score
Price kr248.50
GF Value kr233.28
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Medicover AB Other Long-Term Liabilities?

Medicover AB LTS:0RPS +2.05% 87 Other Long-Term Liabilities is kr622 Mil as of Jun. 2026. GuruFocus rates LTS:0RPS with a GF Score™ of 87/100 and a GF Value™ of kr233.28 (Fairly Valued). The stock has 6 warning signs investors should review.

Medicover AB's other long-term liabilities for the quarter that ended in Jun. 2026 was kr622 Mil.

Medicover AB's quarterly other long-term liabilities declined from Dec. 2025 (kr799 Mil) to Mar. 2026 (kr787 Mil) and declined from Mar. 2026 (kr787 Mil) to Jun. 2026 (kr622 Mil).

Medicover AB's annual other long-term liabilities declined from Dec. 2023 (kr1,541 Mil) to Dec. 2024 (kr1,173 Mil) and declined from Dec. 2024 (kr1,173 Mil) to Dec. 2025 (kr799 Mil).

Medicover AB Other Long-Term Liabilities Related Terms

Medicover AB Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Medicover AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Other Long-Term Liabilities Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,196.54 1,420.38 1,541.44 1,173.27 798.76

Medicover AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,114.51 869.07 798.76 787.38 621.58
LTS:0RPS
87GF Score
Medicover AB LTS:0RPS
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicover AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of kr622 Mil mean?
Medicover AB (LTS:0RPS) has a Other Long-Term Liabilities of kr622 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Medicover AB and its competitors.
Is Medicover AB's Other Long-Term Liabilities too high?
Medicover AB's current Other Long-Term Liabilities is kr622 Mil. Overall, Medicover AB has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Other Long-Term Liabilities compare to HCA and THC?
Medicover AB's Other Long-Term Liabilities of kr622 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Healthcare Providers & Services company?
A good Other Long-Term Liabilities depends on the Healthcare Providers & Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Medicover AB and its competitors. Medicover AB's current Other Long-Term Liabilities is kr622 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr233.28, compared to a current price of kr248.50 — trading 6.5% above its estimated fair value. The current Other Long-Term Liabilities is kr622 Mil. Medicover AB's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Other Long-Term Liabilities is kr622 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued. The current stock price of kr248.50 is trading 6.5% above its estimated GF Value™ of kr233.28. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Other Long-Term Liabilities: kr622 Mil
  • GF Value™: kr233.28 vs. price of kr248.50 (6.5% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
87GF Score

Get the complete analysis for LTS:0RPS

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr248.50
Price
kr233.28
GF Value